(19)
(11) EP 1 890 762 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.05.2021 Bulletin 2021/21

(45) Mention of the grant of the patent:
02.12.2020 Bulletin 2020/49

(21) Application number: 06756220.7

(22) Date of filing: 15.06.2006
(51) International Patent Classification (IPC): 
A61N 2/02(2006.01)
 A61N 2/00(2006.01)
(86) International application number:
PCT/IL2006/000694
(87) International publication number:
WO 2006/134598 (21.12.2006 Gazette 2006/51)

(54)

TRANSCRANIAL MAGNETIC STIMULATION SYSTEM

TRANSKRANIELLES MAGNETISCHES STIMULATIONSSYSTEM

SYSTEME DE STIMULATION MAGNETIQUE TRANSCRANIENNE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 16.06.2005 US 153905

(43) Date of publication of application:
27.02.2008 Bulletin 2008/09

(73) Proprietors:
  • Brainsway, Inc.
    Wilmington, DE 19801 (US)
  • The Government of the United States of America, National Institutes of Health, as represented by the Secretary of the Dpt. Health&Human Services
    Bethesda, MD 20892 (US)
  • Yeda Research and Development Co. Ltd.
    76100 Rehovot (IL)

(72) Inventors:
  • ZANGEN, Abraham
    60000 Jerusalem (IL)
  • ROTH, Yiftach
    60000 Rechelim (IL)
  • MIRANDA, Pedro C.
    P-1600-581 Lisbon (PT)
  • HAZANI, David
    60000 Rechelim (IL)
  • HALLET, Mark
    Bethesda, Maryland 20816 (US)

(74) Representative: HGF 
1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)


(56) References cited: : 
EP-A1- 0 692 993
WO-A2-02/32504
JP-A- H08 280 820
US-A1- 2004 199 041
US-B1- 6 537 197
 WO-A2-02/32504
GB-A- 2 196 853
US-A- 5 738 625
US-B1- 6 179 771
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).